Frequency of cervical intraepithelial neoplasia treatment in a well-screened population.
about
Recommendations on screening for cervical cancerHPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray system.Protecting the underscreened women in developed countries: the value of HPV testThe impact of HPV vaccination on future cervical screening: a simulation study of two birth cohorts in Denmark.Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study.Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in DenmarkEffect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality.Cervical cancer screening at crossroads.Psychological effects of diagnosis and treatment of cervical intraepithelial neoplasia: a systematic review.Natural history of high-grade cervical intraepithelial neoplasia: a review of prognostic biomarkers.Exploring the trend of increased cervical intraepithelial neoplasia detection rates in the Netherlands.Trends in the incidence of cervical cancer and severe precancerous lesions in Denmark, 1997-2012.Evolution of Premalignant Disease.Mothers' and their daughters' use of preventive measures against cervical cancer.Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology.Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.Difference Between Cryotherapy and Follow Up Low Grade Squamous Lesion of Cervix Uteri.Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial.Long-term adherence to follow-up after treatment of cervical intraepithelial neoplasia: nationwide population-based study.
P2860
Q28282866-E3744E75-D6C3-4CB6-A79B-9B18DF974E67Q34006684-AF8094AC-BD0B-4F5F-8E8F-D1DBBAAA4F8AQ34062696-BD49BAAA-B7DF-4CB5-9407-FA218AC4805BQ35959884-F843C4D5-2796-4721-B951-0EBCD34840B5Q36468718-D0541577-08F1-4C18-ADC3-34A7FF901846Q36750670-F46F2E70-6D93-4150-AB58-A3C1BB2857DCQ37503431-25759F87-EF3A-42F8-8BF0-858E6BF31DF0Q38232145-856FDD44-713B-4795-B895-498A261F225EQ38290021-A1A2CEB0-04A7-45EF-BFEC-7FB9FDBEC4D4Q38363737-B5EF37FD-00A5-451F-9128-526275DC51CBQ38414722-8295BAFC-9162-4C63-9140-4300C76A34F1Q39000584-7FC22157-B689-4C20-88C7-071AAAAB1D67Q39296522-CFAF89DC-2774-4D0C-9D64-6ED8A1071F05Q41286222-ACEA6CFE-9FFB-4585-8115-D42E96F44F77Q41620477-D88212FB-727E-477D-8206-ECF634494BA4Q42262377-8CDAD05C-B6C8-49BB-88CC-E228A0CB72F9Q42354242-E54B0644-5609-42A9-B2B3-113D6A0DFB64Q44130257-BD00A695-1BA1-47ED-99D7-03DE104F4CCFQ51205999-42F1E8BF-EE9E-419C-BA80-67C2FAC90721
P2860
Frequency of cervical intraepithelial neoplasia treatment in a well-screened population.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Frequency of cervical intraepithelial neoplasia treatment in a well-screened population.
@en
Frequency of cervical intraepithelial neoplasia treatment in a well-screened population.
@nl
type
label
Frequency of cervical intraepithelial neoplasia treatment in a well-screened population.
@en
Frequency of cervical intraepithelial neoplasia treatment in a well-screened population.
@nl
prefLabel
Frequency of cervical intraepithelial neoplasia treatment in a well-screened population.
@en
Frequency of cervical intraepithelial neoplasia treatment in a well-screened population.
@nl
P2093
P2860
P356
P1476
Frequency of cervical intraepithelial neoplasia treatment in a well-screened population.
@en
P2093
Erik Søgaard Andersen
Matejka Rebolj
Sidsel Svennekjaer Barken
P2860
P304
P356
10.1002/IJC.26248
P577
2011-08-20T00:00:00Z